Medications and Mothers' Milk: A Manual of Lactational Pharmacology
Description:
Medications and Mothers' Milk is now considered the best source of medication information for breastfeeding patients in the world. This new updated version continues to expand, adding numerous new drugs and making changes in existing drugs. Most of the world's latest data on medications affecting breastfeeding mothers and babies are in this new edition, providing you with the most up-to-date information on the use of medications in breastfeeding mothers. Packed with more than 900 drugs, diseases, vaccines, and other material, this easy-to-use reference provides the clinician or mother with easily understood recommendations about the use of medications while breastfeeding. In this edition: · Hundreds of changes in existing monographs. · Over a hundred new drugs or conditions · New changes to contraceptive drug tables. · New oncology drugs added. If you work with pregnant and/or breastfeeding mothers, this definitive reference will help you answer those detailed questions about which medications are safe or unsafe for breastfeeding mothers and babies.
Best prices to buy, sell, or rent ISBN 9780982337998
Frequently Asked Questions about Medications and Mothers' Milk: A Manual of Lactational Pharmacology
The price for the book starts from $6.04 on Amazon and is available from 17 sellers at the moment.
If you’re interested in selling back the Medications and Mothers' Milk: A Manual of Lactational Pharmacology book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Medications and Mothers' Milk: A Manual of Lactational Pharmacology book, the best buyback offer comes from and is $ for the book in good condition.
The Medications and Mothers' Milk: A Manual of Lactational Pharmacology book is in very low demand now as the rank for the book is 8,329,702 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.